Zum Inhalt

Annals of Hematology

Ausgabe 3/2026

Inhalt (43 Artikel)

Plasma exchange combined with anti-B-cell therapy enables comparable outcomes between DSA-positive and DSA-negative aplastic anemia after haplo-HSCT: a propensity-score-matched cohort study

  • Open Access
  • Research

Zhengwei Tan, Jinyu Hu, Yuechao Zhao, Huijin Hu, Qinghong Yu, Yu Zhang, Liqiang Wu, Tonglin Hu, Dijiong Wu, Baodong Ye, Wenbin Liu

Elevated circulating CD10−granulocytic myeloid-derived suppressor cells correlate with disease activity and poor prognosis in patients with diffuse large B-cell lymphoma

  • Open Access
  • Research

Yingwei Li, Weiwei Zhu, Xue Liang, Huiping Wang, Jinli Zhu, Xunyi Jiao, Fan Wu, Zhimin Zhai

The impact of the expression signatures of LncRNAs HBBP1 and XIST on the diagnostic significance of patients with β-Thalassemia

  • Open Access
  • Research

Abdallah M. Gameel, Shimaa Abdelsattar, Zeinab A. Kasemy, Mai El-Sayad Abd El-Hamid, Eman Masoud Abd ElGayed, Basma M. Abdelgawed, Amira Fathy El-Fiky, Mariam E. Labib, Sabry M. Abdelmageed, Mahmoud Ahmed El Hawy, Yasmin Mohsen, Hanan M. Bedair

Dynamic changes in mortality risk factors for acute leukemia patients in the ICU and Post-ICU periods

  • Open Access
  • Research

Linli Lu, Qi Liang, YuHan Yan, Yishu Tang, Erhua Wang, Ying Li, Jian Zhang, Han Xiao, Qian Cheng, Xin Li

The effects of the PHF6 gene mutation on myeloid neoplasms. A single-center cohort underpinned by a systematic review of literature

  • Open Access
  • Brief Report

Edwin U. Suárez, Carlos J. Atencia, Fabio A. Torres-Saavedra, Nazareth Conejero, Rocío Salgado, Mireia Atance-Pararisas, Sara Perlado, Carlos Soto, Juan M. Alonso-Domínguez, Teresa Arquero-Portero, Raquel Mata, Elena Jiménez, J. L. López-Lorenzo, Álvaro V. Arriero, Juana Serrano-López, Socorro M. Rodríguez-Pinilla, Pilar Llamas

Molecular devolution in chronic myelomonocytic leukemia during treatment with decitabine/cedazuridine: A case report

  • Open Access
  • Case Report

Klaus Geissler, Gerlinde Mitterbauer-Hohendanner, Roland Jäger

Efficacy and safety of epcoritamab in relapsed or refractory large B-cell lymphoma: 3-year update from the EPCORE NHL-1 trial

  • Open Access
  • Research

Yasmin H. Karimi, Chan Y. Cheah, Michael Roost Clausen, David Cunningham, Umar Farooq, Tatyana Feldman, Herve Ghesquieres, Wojciech Jurczak, Kim M. Linton, Tycel Phillips, Julie M. Vose, Won Seog Kim, Pegah Jafarinasabian, Barbara D’Angelo Månsson, David Soong, Andrew J. Steele, Zhu Li, Christian W. Eskelund, Martin Hutchings, Catherine Thieblemont

Many faces of non‑deletional α‑thalassaemia variants in neonate and early childhood

  • Open Access
  • Research

Patcharee Komvilaisak, Napat Laoaroon, Pongsatorn Paopongsawan, Junya Jirapradittha, Pakaphan Kiatchoosakun, Kunanya Suwannaying, Ratana Komwilaisak, Worrawalan Lerttham

Relapse following FLT3 inhibitor cessation in FLT3-ITD-positive AML: lessons from two clinical cases

  • Open Access
  • Case Report

Julia-Annabell Georgi, Christoph Röllig, Johannes Schetelig, Christian Thiede, Sascha Brückmann, Martin Bornhäuser, Jan Moritz Middeke

Efficacy and safety of belumosudil for refractory chronic graft-versus-host disease in routine practice

  • Open Access
  • Research

Garret M.K. Leung, Joycelyn P.Y. Sim, Thomas S.Y. Chan, Carol Y.M. Cheung, Eric Tse, Albert K.W. Lie, Harinder Gill, Yok-Lam Kwong

Red blood cell alloimmunization in transfusion-dependent β-thalassemia major patients in Eastern Iran

  • Open Access
  • Research

Mobina Nakhaei Shamahmood, Mohammad Reza Meghdadi, Maziar Nasiri, Mohammad Javad Yousefi, Fatemeh Mezginejad

Burixafor, a CXCR4 inhibitor with a differentiated kinetics profile: results of a phase 2 study for rapid cell mobilization in multiple myeloma and lymphoma patients undergoing transplant

  • Open Access
  • Research

Devki D. Sukhtankar, Pina M. Cardarelli, Bita Jalilizeinali, Gayatri Setia, GaYeon Kim, Li-wen Chang, Cheng-yuan Tsai, Niña G. Caculitan, Michael W. Schuster

Daratumumab-based first-line therapy benefit multiple myeloma patients in a real-world setting: a multi-center retrospective propensity score-match study

  • Open Access
  • Research

Yun Wang, Xiaoqin Chen, Qi Liang, Weida Wang, Jun Luo, Lin Luo, Ru Feng, Yongqiang Wei, Yuyang Tian, Xin Du, Zhenqian Huang, Guoyu Hu, Xiangjun Fu, Shi Tao, Jihao Zhou, Hongling Peng, Yongzhong Su, Hongyu Zhang, Min Dong, Mei Lan, Zhiqiang Sun, Xiuju Wang, Hui Zhou, Liye Zhong, Rober Peter Gale, Yang Liang, Zhongjun Xia

Tisagenlecleucel yields superior patient-reported health-related quality of life compared to autologous stem cell transplantation in patients with relapsed/refractory large B-cell lymphomas

  • Open Access
  • Research

Ellen Obstfelder, Johannes Herrmann, Vladan Vučinić, Andreas Hochhaus, Ulf Schnetzke, Farina Eigendorff

Maladaptive somatic gene rescue as predisposition to JAK2 molecular abnormalities? Insights from an Israeli family

  • Open Access
  • Case Report

Oscar Borsani, Carmelo Gurnari, Daniela Pietra, Elisa Rumi

Balancing safety and efficacy of Bendamustine plus anti CD20 regimens in elderly patients (> 70 y) with follicular lymphoma: a tertiary academic center experience

  • Open Access
  • Correspondence

Mattia D’Antiga, Nicolò Danesin, Giovanni Leone, Marco Carraro, Greta Scapinello, Andrea Serafin, Francesco Angotzi, Alessandro Cellini, Andrea Visentin, Livio Trentin, Francesco Piazza

Real-world outcomes of inotuzumab ozogamicin treatment for adult relapsed or refractory acute lymphoblastic leukemia: a result from Korea post-marketing surveillance

  • Open Access
  • Research

Jae-Ho Yoon, Jung-Hee Lee, Deok-Hwan Yang, June-Won Cheong, Ja Min Byun, Kwai Han Yoo, Juwon Woo, Young-Mee Kim, Seok Lee

Platelet-neutrophil ratio as a potential biomarker for stroke risk stratification in children and young adults with sickle cell anaemia in resource poor settings

  • Open Access
  • Research

Chisom Adaobi Nri-Ezedi, Chilota Chibuife Efobi, Deepika Darbari, Nana-Bilkisu Habib, Andrew Campbell

Real-world outcomes of SLiM-only multiple myeloma: Korean Multicenter Retrospective analysis (KMM2401 study)

  • Open Access
  • Research

Jun Ho Yi, Dok Hyun Yoon, Sung‑Soo Park, Chang‑Ki Min, Ji Hyun Lee, Sung‑Hoon Jung, Youngil Koh, Hyun Jung Lee, Jae-Cheol Jo, Kihyun Kim

Novel therapies in myeloid neoplasms show limited benefit and increased costs over 15 years of follow-up in Southern Finland

  • Open Access
  • Research

Theerin Lanamtieng, Anna Mervaala-Muroke, Laura Toivanen, Kimmo Porkka, Oscar Brück

Epidemiological and comorbidity burden in transfusion-dependent patients with thalassemia and sickle cell disease in Greece

  • Open Access
  • Research

Sophia Delicou, Aikaterini Xydaki, Vassiliki Kamposou, Sabrina Goga, Anthimos Papadopoulos, Christina Rina, Maria Moraki

Factors contributing to the development of hemophilic arthropathy: A real-world study

  • Open Access
  • Research

Jesús Ardila, Melissa Diaz-Puentes, Margarita Guerrero, Andrés Escobar, Jhon Avila-Rueda, Mauricio Jaramillo, Diana Buitrago, Jose Restrepo, Claudia Hernández-Castillo, Laura Prieto-Pinto

Correction to: A meta-analysis of immunosuppressive and Pharmacological therapies in aplastic anaemia with and without Indigenous equine antithymocyte Globulin (eATG)

  • Open Access
  • Correction

Biju George, Reuben Cecil Ross, Sharat Damodar, Tulika Seth, Kanti Tuphan Dolai, Saswata Banerjee, Rajan Manguesh, Pankaj Malhotra

Cryptococcal meningitis complicating immunomodulatory drug maintenance therapy in patients with multiple myeloma: a report of two cases

  • Open Access
  • Letter to the Editor

Fenfen He, Yadong Chen, Zhenchao Huang, Yongjiang Zheng

Clinico-genomic characterization of RAS-mutant acute myeloid leukemia

  • Open Access
  • Research

Robert Yuan, Yiyu Xie, Patricia M. Miron, Anne W. Higgins, Lloyd Hutchinson, Jan Cerny, Shyam A. Patel

Long-term real-world thrombotic and clinical outcomes in polycythemia vera – a hospital-based i2b2 cohort study

  • Open Access
  • Research

Natalie Neumark, Katarzyna Aleksandra Jalowiec, Andre Tichelli, Naomi Porret, Linet Njue, Kristina Vrotniakaite-Bajerciene, Raja Prince-Eladnani, Anne Angelillo-Scherrer, Sara C. Meyer, Alicia Rovó

Overcoming transfusion-refractory anemia: partial splenic embolization to facilitate orthopedic surgery in β-thalassemia

  • Open Access
  • Case Report

Qing Qing Ye, Xian Gui Zhou, Guang Yang, Wan Tao Xie, An Yong Yu, Hai Zhen Duan

Prognostic impact of TP53 mutations in diffuse large B-cell lymphoma

  • Open Access
  • Research

Jiayi Yu, Qiang He, Yuting Yan, Kuntong Liu, Rong Xie, Ji Ma, Liang Wang

Epiregulin levels and their association with prognostic factors in Hodgkin lymphoma: a case-control study

  • Open Access
  • Research

Özden Yildirim Akan, İsmail Demir, Ferda Bilgir, Giray Bozkaya, Şerafettin Ceylan, Oktay Bilgir

Chronic lymphocytic leukemia with IGH/BCL2 fusion and clonal heterogeneity: phenotypic and molecular profiling analysis of a rare case

  • Open Access
  • Case Report

Ting Zhang, Dan Liu, Fanggang Ren, Jian Hao, Feng Ye, Yakun Chen, Bianbian Qiao, Yaofang Zhang, Jianmei Chang, Hongwei Wang, Zhifang Xu

Corilagin induces pyroptosis in AML cells by activating the TXNIP-caspase-3-GSDME pathway

  • Open Access
  • Research

Ganlu Feng, Yizhen Li, Ying Wang, Yue Li, Nianhui Yang, Fangshu Liu, Xiaofan Sun, Kexiu Huang, Danqi Pan, Yingying Wu, Caiping Wu, Weihao Xiao, Xingcheng Liu, Zhuo Lv, Dongfan Wang, Xue Li, Juan Du, Hui Zeng

Correction to: Long-term follow-up of predominantly Asian patients with relapsed/refractory FLT3-mutated acute myeloid leukemia in the phase 3 COMMODORE trial

  • Open Access
  • Correction

Bin Jiang, Jian Li, Ligen Liu, Xin Du, Hao Jiang, Jianda Hu, Xiaoxi Zeng, Taishi Sakatani, Masanori Kosako, Yaru Deng, Vladimir Ivanov, Sergey Bondarenko, Lily Wong Lee Lee, Archrob Khuhapinant, Elena Martynova, Nahla Hasabou, Jamie Jung-Hee An, Jianxiang Wang

Venetoclax and Blinatumomab for adult patients with relapsed/refractory or MRD positive Ph-negative B-cell precursor ALL: phase I part of the GMALL-BLIVEN trial

  • Open Access
  • Brief Report

Lars Fransecky, Walter Fiedler, Christoph Röllig, Tim Sauer, Simon Raffel, Winfried Alsdorf, Lisa Heberling, Britta Steer, Karin Huber, Tim Versteegen, Lea Spory, Dorothee Deckbar, Lena Reiser, Sonja Bendig, Lorenz Bastian, Cecilia Bozzetti, Thomas Beder, Martin Neumann, Monika Brüggemann, Nicola Gökbuget, Claudia Baldus

Intermediate doses cytarabine after induction with CPX-351 for patients with secondary AML: safety and efficacy

  • Open Access
  • Research

Salvatore Perrone, Andrea Corbingi, Calogero Vetro, Fanny Erika Palumbo, Paola Minetto, Carola Riva, Laura Cicconi, Chiara Vernarecci, Roberto Massimo Lemoli, Alessandro Pulsoni, Fabio Guolo

Beyond medical costs: a call for integrating psychosocial support into lymphoma care policy

  • Open Access
  • Correspondence

Jianren Wen, Jingxuan Hu, Guohui Zou

Machine learning and AI-Assisted red blood cell morphology analysis for effective thalassemia screening

  • Open Access
  • Research

Ying Gui, Weiwei Chen, Yuangang Su, Caizhen Qin, Fuyong zhang, Jinmin zhao, Qian Liu

Short-course high-dose cytarabine consolidation therapy before allogeneic hematopoietic stem cell transplantation improves 2-year relapse-free survival but not overall survival in patients with acute myeloid leukemia: a single-center retrospective study

  • Open Access
  • Research

Yu Ma, Yanyan Cheng, Yuting Sun, Xiaotong Zhu, Huifang Zhang, Raj Singh Dhurel, Huanxin Zhang, Qian Sun, Qiong Liu, Wei Chen, Hai Cheng, Zhenyu Li, Bin Pan, Zhiling Yan

Comprehensive geriatric assessment (CGA) scale does not effectively identify elderly AML patients suitable for intensive induction chemotherapy – a multicenter study from Polish Adult Leukemia Group

  • Open Access
  • Research

Bożena Katarzyna Budziszewska, Michał Łomiak, Joanna Barankiewicz, Elżbieta Patkowska, Grzegorz Helbig, Łukasz Bołkun, Anna Irga-Staniukiewicz, Anna Kiżewska, Agnieszka Piekarska, Anna Koclęga, Agnieszka Pluta, Marta Kuydowicz, Sylwia Kościołek-Zgódka, Edyta Cichocka, Agata Malenda, Karol Wójcik, Tomasz Gromek, Piotr Małecki, Sebastian Grosicki, Sebastian Giebel, Agnieszka Wierzbowska, Ewa Lech-Marańda

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

ICI-induzierte Dermatitis: Upadacitinib als vielversprechende Therapieoption

Immunvermittelte Hautreaktionen gehören zu den häufigsten Nebenwirkungen von Immun‑Checkpoint‑Inhibitoren. Eine offene Phase‑2‑Studie untersuchte den JAK‑1‑Inhibitor Upadacitinib bei schwerer ICI‑assoziierter Dermatitis. Die Hautsymptome gingen rasch zurück, schwerwiegende therapieassoziierte Nebenwirkungen wurden nicht beobachtet.

Extrapulmonale Befunde beim Lungenkrebs-Screening – Krebsverdacht gerechtfertigt?

Der Umgang mit Zufallsentdeckungen ist ein vieldiskutiertes Thema im Zusammenhang mit dem Low-Dose-CT-Screening auf Lungenkrebs. Eine Studie hat sich nun speziell mit inzidentellen Befunden befasst, die auf ein extrapulmonales Malignom verdächtig sind.

KI-Chatbots bieten 24/7-Sprechstunde für Patienten

Medizinischen Rat von Chatbots auf der Basis sogenannter künstlicher Intelligenz haben laut Umfragen bereits knapp die Hälfte aller Erwachsenen schon einmal eingeholt. Welche Chancen und Risiken birgt das?

Wie sicher sind Kalziumpräparate bei kardiovaskulärer Vorerkrankung?

Eine weitere Studie weckt Zweifel an der kardiovaskulären Sicherheit von Kalziumsupplementen: Bei Menschen, die bereits einen Herzinfarkt oder Schlaganfall hinter sich hatten, kam es vermehrt zu weiteren Ereignissen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Bildnachweise
Die Leitlinien für Ärztinnen und Ärzte, Eine Person kratzt sich am Rücken über der Schulter/© ryanking999 / stock.adobe.com (Symbolbild mit Fotomodell), Mann erhält einen CT-Scan /© Mark Kostich / stock.adobe.com (Symbolbild mit Fotomodell)